Multi-faceted functions of secretory IgA at mucosal surfaces

B Corthésy - Frontiers in immunology, 2013 - frontiersin.org
Secretory IgA (SIgA) plays an important role in the protection and homeostatic regulation of
intestinal, respiratory, and urogenital mucosal epithelia separating the outside environment …

Secretory IgA: designed for anti-microbial defense

P Brandtzaeg - Frontiers in immunology, 2013 - frontiersin.org
Prevention of infections by vaccination remains a compelling goal to improve public health.
Mucosal vaccines would make immunization procedures easier, be better suited for mass …

[HTML][HTML] Antibodies and tuberculosis

AJ Jacobs, J Mongkolsapaya, GR Screaton… - Tuberculosis, 2016 - Elsevier
Tuberculosis (TB) remains a major public health problem internationally, causing 9.6 million
new cases and 1.5 million deaths worldwide in 2014. The Bacillus Calmette-Guérin vaccine …

Human milk glycoproteins protect infants against human pathogens

B Liu, DS Newburg - Breastfeeding Medicine, 2013 - liebertpub.com
Breastfeeding protects the neonate against pathogen infection. Major mechanisms of
protection include human milk glycoconjugates functioning as soluble receptor mimetics that …

BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny

A Angelidou, J Diray-Arce, MG Conti… - Frontiers in …, 2020 - frontiersin.org
Vaccines have been traditionally developed with the presumption that they exert identical
immunogenicity regardless of target population and that they provide protection solely …

B-cells and antibodies as contributors to effector immune responses in tuberculosis

WF Rijnink, THM Ottenhoff, SA Joosten - Frontiers in immunology, 2021 - frontiersin.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is still a major threat to
mankind, urgently requiring improved vaccination and therapeutic strategies to reduce TB …

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis

S Krishnananthasivam, H Li, R Bouzeyen… - npj Vaccines, 2023 - nature.com
Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (Mtb).
Whilst a functional role for humoral immunity in Mtb protection remains poorly defined …

Pulmonary non-tuberculous mycobacterial infections: current state and future management

KL Chin, ME Sarmiento, N Alvarez-Cabrera… - European Journal of …, 2020 - Springer
Currently, there is a trend of increasing incidence in pulmonary non-tuberculous
mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence …

The research progress in immunotherapy of tuberculosis

J Mi, Y Liang, J Liang, W Gong, S Wang… - Frontiers in cellular …, 2021 - frontiersin.org
Tuberculosis (TB) is a serious public health problem worldwide. The combination of various
anti-TB drugs is mainly used to treat TB in clinical practice. Despite the availability of …

Intranasal vaccination with mannosylated chitosan formulated DNA vaccine enables robust IgA and cellular response induction in the lungs of mice and improves …

M Wu, H Zhao, M Li, Y Yue, S Xiong… - Frontiers in cellular and …, 2017 - frontiersin.org
Induction of specific humoral and cellular immunity in the lung airways is proposed to be
critical for vaccine protection against Mycobacterium tuberculosis (M. tb). To facilitate airway …